Correlation Between Immutep and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Immutep and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and Eyenovia, you can compare the effects of market volatilities on Immutep and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Eyenovia.
Diversification Opportunities for Immutep and Eyenovia
Significant diversification
The 3 months correlation between Immutep and Eyenovia is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Immutep i.e., Immutep and Eyenovia go up and down completely randomly.
Pair Corralation between Immutep and Eyenovia
Given the investment horizon of 90 days Immutep Ltd ADR is expected to generate 0.24 times more return on investment than Eyenovia. However, Immutep Ltd ADR is 4.11 times less risky than Eyenovia. It trades about 0.06 of its potential returns per unit of risk. Eyenovia is currently generating about -0.18 per unit of risk. If you would invest 209.00 in Immutep Ltd ADR on September 15, 2024 and sell it today you would earn a total of 9.00 from holding Immutep Ltd ADR or generate 4.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immutep Ltd ADR vs. Eyenovia
Performance |
| Timeline |
| Immutep Ltd ADR |
| Eyenovia |
Immutep and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immutep and Eyenovia
The main advantage of trading using opposite Immutep and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
| Eyenovia vs. Emergent Biosolutions | Eyenovia vs. Bausch Health Companies | Eyenovia vs. Neurocrine Biosciences | Eyenovia vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |